Clinical Trials Logo

Clinical Trial Summary

The main aim of this study is to capture management and treatment outcome data in participants with short bowel syndrome and chronic intestinal failure (SBS-IF) that underwent intestinal transplantation in Brazil. This study is about collecting data available in the participant's medical record and will also describe the demographic and clinical characteristics of these participants. No medication will be provided to participants in this study. Clinical data will be collected from a period up to 10 years before the day of the intestinal transplantation. No clinic visits will be required as part of participation in this study.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05113082
Study type Observational
Source Takeda
Contact
Status Completed
Phase
Start date May 21, 2022
Completion date October 15, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05371028 - A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada
Completed NCT01674478 - Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies Phase 2
Recruiting NCT05561647 - A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using GATTEX